Succinylcholine and rocuronium are widely used to facilitate rapid sequence
induction (RSI) intubation in intensive care. Concerns relate to side effects of
succinylcholine and to a slower onset and inferior intubation conditions associated
with rocuronium. So far succinylcholine and rocuronium have not been compared in
an adequately powered randomized trial in intensive care. Accordingly, the aim of the
present study was to compare the incidence of hypoxemia after rocuronium or
succinylcholine in critically ill patients requiring an emergent RSI.
https://docs.google.com/viewer?a=v&pid=explorer&chrome=true&srcid=0B9_5O4o-ZNypMjY4NDcxOWYtNWIyOS00MTMyLTkwNDQtZjEyOTQwMGI4ZGYw&hl=en_US
induction (RSI) intubation in intensive care. Concerns relate to side effects of
succinylcholine and to a slower onset and inferior intubation conditions associated
with rocuronium. So far succinylcholine and rocuronium have not been compared in
an adequately powered randomized trial in intensive care. Accordingly, the aim of the
present study was to compare the incidence of hypoxemia after rocuronium or
succinylcholine in critically ill patients requiring an emergent RSI.
https://docs.google.com/viewer?a=v&pid=explorer&chrome=true&srcid=0B9_5O4o-ZNypMjY4NDcxOWYtNWIyOS00MTMyLTkwNDQtZjEyOTQwMGI4ZGYw&hl=en_US
Commentaires
Enregistrer un commentaire